Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron E Hoffman

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Chronobiology International|November 15, 2011
Epigenetic impact of long-term shiftwork: pilot evidence from circadian genes and whole-genome methylation analysisYong Zhu, Richard G Stevens, Aaron E Hoffman, et al.
BMC Cancer|March 26, 2010
Phenotypic effects of the circadian gene Cryptochrome 2 on cancer-related pathwaysAaron E Hoffman, Tongzhang Zheng, Yue Ba, et al.
Journal of Pineal Research|May 12, 2019
Epigenetic inhibition of the tumor suppressor ARHI by light at night-induced circadian melatonin disruption mediates STAT3-driven paclitaxel resistance in breast cancerShulin Xiang, Robert T Dauchy, Aaron E Hoffman, et al.
Cancer Research|July 2, 2009
microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysisAaron E Hoffman, Tongzhang Zheng, Chunhui Yi, et al.
Sleep Medicine|April 9, 2013
Advanced sleep schedules affect circadian gene expression in young adults with delayed sleep schedulesYong Zhu, Alan Fu, Aaron E Hoffman, et al.
Cancer Research|March 26, 2009
Clock-cancer connection in non-Hodgkin's lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2Aaron E Hoffman, Tongzhang Zheng, Richard G Stevens, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 18, 2010
The core circadian gene Cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signalingAaron E Hoffman, Tongzhang Zheng, Chun-Hui Yi, et al.
Breast Cancer Research and Treatment|August 4, 2009
The circadian gene NPAS2 is a novel prognostic biomarker for breast cancerChunhui Yi, Lina Mu, Irene A Rigault de la Longrais, et al.
Cancer Research|February 4, 2010
CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analysesAaron E Hoffman, Chun-Hui Yi, Tongzhang Zheng, et al.
Cancer Research|November 26, 2009
Testing the circadian gene hypothesis in prostate cancer: a population-based case-control studyYong Zhu, Richard G Stevens, Aaron E Hoffman, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Chronobiology International|November 15, 2011
Epigenetic impact of long-term shiftwork: pilot evidence from circadian genes and whole-genome methylation analysisYong Zhu, Richard G Stevens, Aaron E Hoffman, et al.
BMC Cancer|March 26, 2010
Phenotypic effects of the circadian gene Cryptochrome 2 on cancer-related pathwaysAaron E Hoffman, Tongzhang Zheng, Yue Ba, et al.
Journal of Pineal Research|May 12, 2019
Epigenetic inhibition of the tumor suppressor ARHI by light at night-induced circadian melatonin disruption mediates STAT3-driven paclitaxel resistance in breast cancerShulin Xiang, Robert T Dauchy, Aaron E Hoffman, et al.
Cancer Research|July 2, 2009
microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysisAaron E Hoffman, Tongzhang Zheng, Chunhui Yi, et al.
Sleep Medicine|April 9, 2013
Advanced sleep schedules affect circadian gene expression in young adults with delayed sleep schedulesYong Zhu, Alan Fu, Aaron E Hoffman, et al.
Cancer Research|March 26, 2009
Clock-cancer connection in non-Hodgkin's lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2Aaron E Hoffman, Tongzhang Zheng, Richard G Stevens, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 18, 2010
The core circadian gene Cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signalingAaron E Hoffman, Tongzhang Zheng, Chun-Hui Yi, et al.
Breast Cancer Research and Treatment|August 4, 2009
The circadian gene NPAS2 is a novel prognostic biomarker for breast cancerChunhui Yi, Lina Mu, Irene A Rigault de la Longrais, et al.
Cancer Research|February 4, 2010
CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analysesAaron E Hoffman, Chun-Hui Yi, Tongzhang Zheng, et al.
Cancer Research|November 26, 2009
Testing the circadian gene hypothesis in prostate cancer: a population-based case-control studyYong Zhu, Richard G Stevens, Aaron E Hoffman, et al.
Pageof 3